| Name | cimicoxib |
|---|---|
| Synonyms |
4-[4-chloro-5-(3-fluoro-4-methoxyphenyl)imidazol-1-yl]benzenesulfonamide
UR-8880 Cimicoxib |
| Description | Cimicoxib (CX) is an orally active potent and selective COX-2 (cyclo-oxygenase-2) inhibitor. Cimicoxib exhibits promising anti-inflammatory and analgesic activity. The PK parameters of Cimicoxib in dogs given precise (2 mg/kg) and approximate doses (1.95-2.5 mg/kg) are similar[1]. |
|---|---|
| Related Catalog | |
| Target |
COX-2 |
| References |
| Density | 1.49g/cm3 |
|---|---|
| Boiling Point | 593.1ºC at 760 mmHg |
| Molecular Formula | C16H13ClFN3O3S |
| Molecular Weight | 381.81 |
| Flash Point | 312.5ºC |
| Exact Mass | 381.03500 |
| PSA | 95.59000 |
| LogP | 4.76890 |
| Vapour Pressure | 4.91E-14mmHg at 25°C |
| Index of Refraction | 1.649 |